Study Information

Name of the study

Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease

Study sponsor

Alzheon Inc.

Disease

Early Alzheimer's disease

Phase

Phase II

Information about the drug that will be tested in the studies

Name of the drug

ALZ-801

Where and when will the study be conducted?

European countries involved in the trial (active)

• Czechia
• The Netherlands

Information for your doctor

Clinicaltrials.gov identifier

NCT04693520 

Link to full text

https://www.clinicaltrials.gov/ct2/show/NCT04693520